Published in Emerg Microbes Infect on January 07, 2015
Thiol-Capped Gold Nanoparticles Swell-Encapsulated into Polyurethane as Powerful Antibacterial Surfaces Under Dark and Light Conditions. Sci Rep (2016) 0.78
A controlled antibiotic release system to prevent orthopedic-implant associated infections: An in vitro study. Eur J Pharm Biopharm (2015) 0.77
Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol (2001) 11.67
Treatment of infections associated with surgical implants. N Engl J Med (2004) 8.49
Riddle of biofilm resistance. Antimicrob Agents Chemother (2001) 7.19
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother (2003) 4.59
New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J Bacteriol (2007) 2.30
Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res (2002) 2.20
Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother (2006) 2.05
A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol Microbiol (2008) 2.03
Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med (2012) 1.96
Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol (2007) 1.89
Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother (1999) 1.57
New approaches for treating staphylococcal biofilm infections. Ann N Y Acad Sci (2011) 1.56
The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology (2005) 1.43
Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J (2002) 1.43
Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother (2011) 1.42
Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiol (2006) 1.27
Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother (2001) 1.19
Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. Biosci Biotechnol Biochem (2001) 1.06
Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. Yale J Biol Med (2010) 1.06
Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. PLoS One (2012) 1.02
Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother (2008) 1.02
Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus. J Antibiot (Tokyo) (2003) 0.99
Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system. Adv Exp Med Biol (2008) 0.97
Genetic regulation of the intercellular adhesion locus in staphylococci. Front Cell Infect Microbiol (2012) 0.97
Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth. J Antibiot (Tokyo) (2010) 0.96
High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda. BMC Res Notes (2011) 0.87
Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections. Invest Ophthalmol Vis Sci (2012) 0.87
Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis. Acta Pharmacol Sin (2012) 0.85
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. J Clin Microbiol (2011) 0.84
Phenotypic and genetic analysis of biofilm formation by Staphylococcus epidermidis. Medicina (Kaunas) (2012) 0.84
Candida albicans survival and biofilm formation under starvation conditions. Int Endod J (2012) 0.84
Evaluation of diffusion and dilution methods to determine the antimicrobial activity of water-soluble chitosan derivatives. J Appl Microbiol (2013) 0.81
Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein. Appl Microbiol Biotechnol (2014) 0.81
Prevalence of methicillin-resistant Staphylococcus aureus in elective surgical patients at a public teaching hospital: an analysis of 1039 patients. Am Surg (2012) 0.80
Thiazolidione derivatives as novel antibiofilm agents: design, synthesis, biological evaluation, and structure-activity relationships. Eur J Med Chem (2010) 0.79
[Does the emergence of antibiotic resistance announce the return of the dark ages?]. Ann Biol Clin (Paris) (2011) 0.76
Erratum: Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Emerg Microbes Infect (2015) 0.79